Trelegy Ellipta (fluticasone furoate/umeclidinium bromide/vilanterol) - GSK, Innoviva, Theravance Biopharma
Trelegy Ellipta: Newly added patents in Orange Book (Orange Book) - May 30, 2025 - Expiry on Jun 14, 2027, Oct 2, 2027, Feb 5, 2028 
Patent Asthma • Chronic Obstructive Pulmonary Disease • Respiratory Diseases
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
 
May 30, 2025
 
 
4603338f-cfd0-4f9a-a494-93a8bc50fc52.png